IBDEI1LA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26584,1,4,0)
 ;;=4^H47.012
 ;;^UTILITY(U,$J,358.3,26584,2)
 ;;=^5006106
 ;;^UTILITY(U,$J,358.3,26585,0)
 ;;=H47.013^^130^1293^14
 ;;^UTILITY(U,$J,358.3,26585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26585,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Bilateral
 ;;^UTILITY(U,$J,358.3,26585,1,4,0)
 ;;=4^H47.013
 ;;^UTILITY(U,$J,358.3,26585,2)
 ;;=^5006107
 ;;^UTILITY(U,$J,358.3,26586,0)
 ;;=H20.9^^130^1294^14
 ;;^UTILITY(U,$J,358.3,26586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26586,1,3,0)
 ;;=3^Iridocyclitis,Unspec
 ;;^UTILITY(U,$J,358.3,26586,1,4,0)
 ;;=4^H20.9
 ;;^UTILITY(U,$J,358.3,26586,2)
 ;;=^5005170
 ;;^UTILITY(U,$J,358.3,26587,0)
 ;;=H21.03^^130^1294^11
 ;;^UTILITY(U,$J,358.3,26587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26587,1,3,0)
 ;;=3^Hyphema,Bilateral
 ;;^UTILITY(U,$J,358.3,26587,1,4,0)
 ;;=4^H21.03
 ;;^UTILITY(U,$J,358.3,26587,2)
 ;;=^5005174
 ;;^UTILITY(U,$J,358.3,26588,0)
 ;;=H21.01^^130^1294^13
 ;;^UTILITY(U,$J,358.3,26588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26588,1,3,0)
 ;;=3^Hyphema,Right Eye
 ;;^UTILITY(U,$J,358.3,26588,1,4,0)
 ;;=4^H21.01
 ;;^UTILITY(U,$J,358.3,26588,2)
 ;;=^5005172
 ;;^UTILITY(U,$J,358.3,26589,0)
 ;;=H21.02^^130^1294^12
 ;;^UTILITY(U,$J,358.3,26589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26589,1,3,0)
 ;;=3^Hyphema,Left Eye
 ;;^UTILITY(U,$J,358.3,26589,1,4,0)
 ;;=4^H21.02
 ;;^UTILITY(U,$J,358.3,26589,2)
 ;;=^5005173
 ;;^UTILITY(U,$J,358.3,26590,0)
 ;;=H21.1X2^^130^1294^19
 ;;^UTILITY(U,$J,358.3,26590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26590,1,3,0)
 ;;=3^Vascular Disorders of Iris/Ciliary Body,Left Eye
 ;;^UTILITY(U,$J,358.3,26590,1,4,0)
 ;;=4^H21.1X2
 ;;^UTILITY(U,$J,358.3,26590,2)
 ;;=^5005176
 ;;^UTILITY(U,$J,358.3,26591,0)
 ;;=H21.1X3^^130^1294^20
 ;;^UTILITY(U,$J,358.3,26591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26591,1,3,0)
 ;;=3^Vascular Disorders of Iris/Ciliary Body,Bilateral
 ;;^UTILITY(U,$J,358.3,26591,1,4,0)
 ;;=4^H21.1X3
 ;;^UTILITY(U,$J,358.3,26591,2)
 ;;=^5005177
 ;;^UTILITY(U,$J,358.3,26592,0)
 ;;=H21.1X1^^130^1294^21
 ;;^UTILITY(U,$J,358.3,26592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26592,1,3,0)
 ;;=3^Vascular Disorders of Iris/Ciliary Body,Right Eye
 ;;^UTILITY(U,$J,358.3,26592,1,4,0)
 ;;=4^H21.1X1
 ;;^UTILITY(U,$J,358.3,26592,2)
 ;;=^5005175
 ;;^UTILITY(U,$J,358.3,26593,0)
 ;;=H21.231^^130^1294^8
 ;;^UTILITY(U,$J,358.3,26593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26593,1,3,0)
 ;;=3^Degeneration of Iris,Right Eye
 ;;^UTILITY(U,$J,358.3,26593,1,4,0)
 ;;=4^H21.231
 ;;^UTILITY(U,$J,358.3,26593,2)
 ;;=^5005187
 ;;^UTILITY(U,$J,358.3,26594,0)
 ;;=H21.233^^130^1294^6
 ;;^UTILITY(U,$J,358.3,26594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26594,1,3,0)
 ;;=3^Degeneration of Iris,Bilateral
 ;;^UTILITY(U,$J,358.3,26594,1,4,0)
 ;;=4^H21.233
 ;;^UTILITY(U,$J,358.3,26594,2)
 ;;=^5005189
 ;;^UTILITY(U,$J,358.3,26595,0)
 ;;=H21.232^^130^1294^7
 ;;^UTILITY(U,$J,358.3,26595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26595,1,3,0)
 ;;=3^Degeneration of Iris,Left Eye
 ;;^UTILITY(U,$J,358.3,26595,1,4,0)
 ;;=4^H21.232
 ;;^UTILITY(U,$J,358.3,26595,2)
 ;;=^5005188
 ;;^UTILITY(U,$J,358.3,26596,0)
 ;;=H21.541^^130^1294^18
 ;;^UTILITY(U,$J,358.3,26596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26596,1,3,0)
 ;;=3^Posterior Synechiae,Right Eye
 ;;^UTILITY(U,$J,358.3,26596,1,4,0)
 ;;=4^H21.541
 ;;^UTILITY(U,$J,358.3,26596,2)
 ;;=^5005251
 ;;^UTILITY(U,$J,358.3,26597,0)
 ;;=H21.543^^130^1294^16
 ;;^UTILITY(U,$J,358.3,26597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26597,1,3,0)
 ;;=3^Posterior Synechiae,Bilateral
